Remdesivir tied to lower COVID death rates in hospital patients receiving oxygen

A comparative-effectiveness study that spanned the dominance of SARS-CoV-2 variants of concern finds that the antiviral drug remdesivir significantly reduced in-hospital COVID-19 death rates among adults receiving supplemental oxygen on admission.

Full story

#1

Recent research on Paxlovid shows there is "solid data on its effectiveness," a co-author of the study told HealthLeaders. ...

A new personal protective equipment manufacturing company is set to open in Cincinnati next year. ...